Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor

Overview of attention for article published in BMC Cancer, May 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

peer_reviews: 1 peer review site

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Peer reviews Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

GLP-1/Sigma/RAGE receptors: An evolving picture of Alzheimer's disease pathology and treatment

Article in Ageing Research Reviews (November 2023)

Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders

Article in CNS Drugs (May 2023)

Development of Fluorescent 4‑[4-(3H‑Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques

Article in Journal of Medicinal Chemistry (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.